^{99m}Tc labeled levofloxacin as an infection imaging agent: a novel method for labeling levofloxacin using cysteine\cdot HCl as co-ligand and in vivo study

Authors: SYED ALI RAZA NAQVI, MALIK MUHAMMAD ISHFAQ, ZULFIQAR ALI KHAN, SAEED AHMAD NAGRA, IFTIKHAR HUSSAIN BUKHARI, ABDULLAH IJAZ HUSSAIN, NASIR MAHMOOD, SOHAIL ANJUM SHAHZAD, ASMA HAQUE, TANVEER HUSSAIN BOKHARI

Abstract: Levofloxacin was labeled with ^{99m}Tc using cysteine\cdot HCl as co-ligand and SnCl_2.2H_2O as reducing agent. The influence of various parameters such as amount of cysteine\cdot HCl, reducing agent, pH value, and reaction time on labeling process was studied. After optimizing the conditions the labeling was performed at pH 5 using 1 mg of levofloxacin, 500 \mu g of cysteine\cdot HCl, 50 \mu g of SnCl_2.2H_2O, and 15 min reaction time. The radiochemical purity was determined with the help of instant thin layer chromatography (ITLC) and reverse phase high performance liquid chromatography (RP-HPLC) which was more than 95% and was stable for up to 6 h. Biodistribution of ^{99m}Tc-levofloxacin (^{99m}Tc-lefx) was studied in infection induced rat models using live Staphylococcus aureus and heat killed S. aureus (sterile inflammation model). In the case of the live S. aureus induced abscess model, the accumulation of ^{99m}Tc-lefx at target was 3.96, which was higher than that of ^{99m}Tc-ciprofloxacin (^{99m}Tc-cifx), taken as the control.

Keywords: Infection, ^{99m}Tc-levofloxacin, co-ligand, scintigraphy, biodistribution, infection model

Full Text: PDF